Product Program year 2025 Source: CMS Open Payments

OptiCross 6

Device OptiCross6_IC

PDI 08714729904762

Open in the dashboard

General payments

$8,672

179 payments

Research payments

$0

0 payments

Through program year 2025, $8,672 in general payments and $0 in research payments were reported against OptiCross 6 (OptiCross6_IC).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $8,599 174
2024 General $73 5

Breakdown

Who paid General payments · program years 2024–2025
  1. Boston Scientific Corporation $8,672 179 payments
Top recipients General payments · program year 2025
  1. Seyed Mohammad Khalafi Thoracic Surgery (Cardiothoracic Vascular Surgery) · Fort Worth, TX $492 6% · 4 payments
  2. Alisa Thamwiwat Interventional Cardiology · Bedford, TX $354 4% · 3 payments
  3. Aiswarya Sundaram Interventional Cardiology · Arlington, TX $262 3% · 5 payments
  4. Karthik Anand Interventional Cardiology · Fort Worth, TX $249 3% · 2 payments
  5. Nethuja Salagundla Internal Medicine · Lafayette, LA $249 3% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $4,233 50% · 61 practitioners
  2. Cardiovascular Disease Internal Medicine $2,137 25% · 23 practitioners
  3. Thoracic Surgery (Cardiothoracic Vascular Surgery) $605 7% · 2 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $409 5% · 7 practitioners
  5. Internal Medicine $388 5% · 4 practitioners

The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $3,871 45% · 25 recipients
  2. Illinois $1,518 18% · 14 recipients
  3. North Carolina $639 7% · 14 recipients
  4. Nevada $396 5% · 12 recipients
  5. Louisiana $308 4% · 5 recipients

The top 5 of 22 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

179 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record